Nippon Shinyaku
Founded Year
1919About Nippon Shinyaku
Nippon Shinyaku is a research-oriented pharmaceutical company dedicated to research and development of drugs. Areas of specialty for both R&D and marketing by Nippon Shinyaku include urology, hematology, intractable and rare diseases, gynaecology, and otorhinolaryngology. By implementing its own drug discovery research, licensing-in from other companies and product lifecycle management, Nippon Shinyaku is striving to address unmet medical needs and launch pharmaceuticals.
Missing: Nippon Shinyaku's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Nippon Shinyaku's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Nippon Shinyaku Patents
Nippon Shinyaku has filed 49 patents.
The 3 most popular patent topics include:
- Muscular dystrophy
- Rare diseases
- Olfactory receptors
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/10/2019 | 1/24/2023 | Amines, Ammonium compounds, Quaternary ammonium compounds, Chelating agents, Proteinogenic amino acids | Grant |
Application Date | 5/10/2019 |
|---|---|
Grant Date | 1/24/2023 |
Title | |
Related Topics | Amines, Ammonium compounds, Quaternary ammonium compounds, Chelating agents, Proteinogenic amino acids |
Status | Grant |
Latest Nippon Shinyaku News
Mar 17, 2023
16-03-2023 Danish drugmaker Pharmacosmos has announced the launch of its intravenous iron deficiency anemia medicine MonoVer (ferric derisomaltose) in Japan. The launch follows a successful bid for reimbursement by the firm’s strategic partner Nippon Shinyaku, which will undertake commercialization in the country. Chief executive Tobias Christensen said: “The launch in Japan marks a milestone for Pharmacosmos, since we are now represented with ferric derisomaltose in the three largest global pharma markets.” He added: “Our product fits with the needs of Japanese patients and hospitals, and the strength of our partner Nippon Shinyaku makes us see this opportunity as very promising for Pharmacosmos.”
Nippon Shinyaku Frequently Asked Questions (FAQ)
When was Nippon Shinyaku founded?
Nippon Shinyaku was founded in 1919.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.